Clinical Evidence

Research & Citations

Clinical considerations, preparation quality, disclosures, and peer-reviewed references for PRP therapy

James C. Kasper, M.D. • Central Coast Orthopedics

Scroll

The following information represents published clinical research involving PRP therapy. These studies vary in design, patient population, methodology, and level of evidence. Inclusion of any study does not imply universal effectiveness or guarantee of outcome. Evidence quality and study results vary by condition and patient characteristics. Individual results vary, and not all patients are candidates for PRP therapy. Clinical decision-making requires individualized assessment.

Potential Benefits of PRP Therapy

Minimally Invasive

A non-surgical, office-based procedure. Most patients are able to resume their usual activities shortly after treatment, though individual protocols may vary.

Autologous Preparation

PRP is derived from your own blood, utilizing your body's own growth factors. Because the preparation is autologous, the risk of allergic reaction or rejection is minimal.

Supported by Clinical Literature

A growing body of peer-reviewed literature has examined PRP across a range of musculoskeletal conditions, with many studies reporting improvements in pain and function in select patient populations.

Comparative Studies Available

Several randomized controlled trials and systematic reviews have compared PRP to corticosteroids and hyaluronic acid in the setting of knee osteoarthritis, with some studies reporting different outcome measures across treatment groups.

In a single study published in the American Journal of Sports Medicine (n=20), patients with chronic elbow tendinosis treated with PRP reported reductions in pain scores at week four and at six months. At final follow-up, the majority of patients in the PRP group reported satisfaction with treatment. Study conclusions are specific to the study population and design and may not be generalizable to all patients.

In a separate study, MRI findings in patients receiving PRP for knee osteoarthritis suggested findings consistent with delayed disease progression in some participants at follow-up. Evidence quality varies by condition, and PRP may be considered as one component of a comprehensive orthopedic treatment plan.

PRP Preparation & Quality

PRP composition varies significantly depending on the preparation system used. Below is a factual description of the protocol utilized in our clinic.

Platelet Concentration

For most patients, our preparation achieves over 1 billion platelets per mL — a concentration level that has been explored in published research as potentially relevant to clinical outcomes.

Growth Factor Content

The concentrated platelet preparation contains growth factors that are delivered to the treatment site.

Platelet Recovery Rate

Our system recovers over 80% of the platelets present in the initial blood draw.

Leukocyte-Poor Preparation

Red blood cells and neutrophils are removed prior to injection, which has been associated in some studies with reduced post-injection inflammation.

Patient Selection & Candidacy

PRP may be considered for patients who have not achieved adequate improvement with conservative treatments such as steroid injections, viscosupplementation, physical therapy, or bracing. Not everyone is a candidate for PRP therapy. A thorough clinical evaluation — including review of imaging, diagnosis, and treatment history — is required to determine whether PRP is appropriate for your specific condition. PRP may also be discussed as one option for patients who wish to explore non-surgical approaches prior to considering surgical intervention.

Limitations & Disclosures

Limitations of PRP Therapy

Outcomes vary. Individual responses to PRP therapy differ based on the condition treated, severity, patient health, and other factors. Not all patients experience symptom improvement.
Not effective for all diagnoses. PRP has been studied for a range of musculoskeletal conditions, but evidence quality varies by diagnosis. Some conditions have stronger supporting evidence than others.
Evidence is evolving. While a growing body of literature supports the use of PRP in certain orthopedic applications, it is not yet considered standard of care for all conditions discussed on this site.
Typically not covered by insurance. PRP is not typically covered by commercial insurance companies or Medicare and is provided as a cash pay procedure.
PRP does not replace surgery. PRP may be considered prior to surgical intervention in appropriate cases, but it is not a substitute for surgery when surgery is clinically indicated.

FDA & Regulatory Information

PRP is prepared from the patient's own blood at the point of care and is regulated under the practice of medicine. PRP is not an FDA-approved drug or biologic product. The equipment used to prepare PRP has received FDA clearance for the purpose of separating blood components.

The clinical studies referenced on this website reflect published peer-reviewed research. Citation of these studies does not imply FDA endorsement of PRP for any specific condition.

Patient Evaluation Required

Not everyone is a candidate for PRP therapy. A comprehensive clinical evaluation is required before treatment, which may include:

  • Review of medical history and current medications
  • Physical examination
  • Diagnostic imaging (X-ray, MRI, ultrasound)
  • Discussion of diagnosis and all available treatment options

Treatment decisions are made collaboratively between physician and patient based on clinical findings.

Research & References

The following peer-reviewed publications support some of the clinical evidence presented on this site. Readers are encouraged to review the original studies for full methodologies, sample sizes, and reported limitations. Study conclusions are specific to each study's population and design.